Search Result
20 search results for Histiocytic Neoplasms
NCCN Guidelines Histiocytic Neoplasms
NCCN Guidelines Histiocytic Neoplasms, NCCN clinical practice guidelines in oncology – Histiocytic Neoplasms
https://www.nccn.org/professionals/physician_gls/pdf/histiocytic_neoplasms.pdfErdheim-Chester Disease
NCCN clinical practice guidelines in oncology – Histiocytic Neoplasms
https://www.nccn.org/professionals/physician_gls/pdf/histiocytic_neoplasms.pdfLangerhans Cell Histiocytosis
NCCN clinical practice guidelines in oncology – Histiocytic Neoplasms
https://www.nccn.org/professionals/physician_gls/pdf/histiocytic_neoplasms.pdfRosai-Dorfman Disease
NCCN clinical practice guidelines in oncology – Histiocytic Neoplasms
https://www.nccn.org/professionals/physician_gls/pdf/histiocytic_neoplasms.pdfNCCN Guidelines Panels
Cancers Panel Histiocytic Neoplasms, Myeloproliferative Neoplasms Panel Neuroblastoma
https://www.nccn.org/education-research/continuing-education-(ce)/nccn-guidelines-in-practice/nccn-guidelines-panelsDrugs and Biologics Reviewer Acknowledgement
. Lurie Comprehensive Cancer Center of Northwestern University Histiocytic Neoplasms, Stanford Cancer Institute Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene, Stanford Cancer Institute Myeloproliferative Neoplasms Aaron T. Gerds, Center Uterine Neoplasms Nadeem R. Abu-Rustum, MD
https://www.nccn.org/compendia-templates/compendia/drugs-and-biologics-compendia/drugs-and-biologics-reviewer-acknowledgementBiomarkers Compendium Reviewer Acknowledgment
Comprehensive Cancer Center of Northwestern University Histiocytic Neoplasms, O'Neal Comprehensive Cancer Center at UAB Myeloid/Lymphoid Neoplasms with Eosinophilia, Myeloproliferative Neoplasms Lucia Masarova, MD, Center Uterine Neoplasms Brooke E. Howitt, MD
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendium/biomarkers-compendium-reviewer-acknowledgmentRadiation Therapy Compendium Reviewer Acknowledgement
Histiocytic Neoplasms Ann C. Raldow, MD, MPH UCLA, of Hope National Medical Center Uterine Neoplasms Junzo Chino
https://www.nccn.org/compendia-templates/compendia/radiation-therapycompendium/radiation-therapy-compendium-reviewer-acknowledgementPermission to Cite or Use NCCN Content
Cancers Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer, Cancers Hepatobiliary Cancers Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi, Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Lung Cancer Screening, Factors Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney, Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-contentTransparency Process
Disclosures/Attendance Version: 2.2025 ( Uterine Neoplasms ) Date: 2025-01-27 Transparency, Panel Disclosures/Attendance Version: 1.2025 ( Uterine Neoplasms ) Date, Version: 3.2024 ( Uterine Neoplasms ) Date: 2024-06-20 Transparency Panel, Panel Disclosures/Attendance Version: 2.2024 ( Uterine Neoplasms ) Date: 2024-02-29, Neoplasms ) Date: 2023-06-30 Transparency Panel Disclosures/Attendance Version: 1.2024
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines Panels
Cancers Panel Histiocytic Neoplasms, Myeloproliferative Neoplasms Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsTreatment by Cancer Type
Version: 1.2025 Histiocytic Neoplasms, Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version: 2.2025 Myeloproliferative Neoplasms, Neoplasms Version: 3.2025 Vaginal Cancer
https://www.nccn.org/guidelines/category_1Resume Screening
Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Melanoma: Cutaneous Melanoma, Myelodysplastic Syndromes Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Myeloproliferative Neoplasms Neuroblastoma Neuroendocrine and Adrenal Tumors Non-Small Cell Lung, Uterine Neoplasms Vaginal Cancer Vulvar Cancer Waldenström Macroglobulinemia/Lymphoplasmacytic, Mesothelioma Mouth Cancer Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms
https://www.nccn.org/covid-19/resume-screeningSubmission Request Form
- 1.2023 Hepatocellular Carcinoma - 1.2025 Histiocytic Neoplasms - 3.2024 Hodgkin Lymphoma - 2.2025, Multiple Myeloma - 2.2025 Myelodysplastic Syndromes - 2.2025 Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions - 2.2025 Myeloproliferative Neoplasms - 1.2025 Neuroblastoma, - 2.2025 Thymomas and Thymic Carcinomas - 2.2025 Thyroid Carcinoma - 1.2025 Uterine Neoplasms
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formHIT
Hepatocellular Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Melanoma, Multiple Myeloma Myelodysplastic Syndromes Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Myeloproliferative Neoplasms Neuroblastoma Neuroendocrine and Adrenal Tumors, Thyroid Carcinoma Uterine Neoplasms Vaginal Cancer Vulvar Cancer Waldenström Macroglobulinemia, Myeloproliferative Neoplasms Nasopharyngeal Cancer Nausea and Vomiting Neuroendocrine Tumors Non-Small Cell
https://www.nccn.org/redirects/hitGuidelines With Evidence Blocks
1.2025 Histiocytic Neoplasms Version 3.2024 Hodgkin Lymphoma Version 2.2025, Myelodysplastic Syndromes Version 2.2025 Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Version 2.2025 Myeloproliferative Neoplasms Version 1.2025, Uterine Neoplasms Version 3.2025 Vaginal Cancer Version 5.2025 Vulvar
https://www.nccn.org/guidelines/guidelines-with-evidence-blocksChemotherapy Order Templates Reviewer Acknowledgement
Roswell Park Comprehensive Cancer Center Histiocytic Neoplasms, Moffitt Cancer Center Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine, Fox Chase Cancer Center Myeloproliferative Neoplasms, University of Michigan Rogel Cancer Center Uterine Neoplasms
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagementAdvocacy and Support Groups
Myeloproliferative Neoplasms Neuroendocrine Tumors Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal, Association is a global nonprofit organization supporting people impacted by all histiocytic disorders, awareness for all histiocytic disorders, and funding research that will lead us to cures. The Association, Dorfman Disease (RDD), Xanthogranuloma (JXG/XG), malignant histiocytosis including histiocytic sarcoma
https://www.nccn.org/patientresources/patient-resources/resources-for-patients-caregivers/advocacy-and-support-groupsSubmission Request History
for Uterine Neoplasms Submitted by Merck & Co., Inc. on 06/17/2020 Pembrolizumab for Vulvar Cancer, testing for Uterine Neoplasms Submitted by Foundation Medicine, Inc. on 06/30/2020 Avelumab, by Eisai Inc. on 02/11/2021 Lenvatinib and pembrolilzumab for Uterine Neoplasms Submitted, & Co., Inc. on 03/19/2021 Pembrolizumab and Lenvatinib for Uterine Neoplasms Submitted, Dostarlimab-gxly (Uterine Neoplasms) Submitted by GlaxoSmithKline on 04/22/2021
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-history